Contribute Try STAT+ Today

A gout drug shows promise for Covid-19, but skeptics worry about trusting science by press release

Outside experts said the data, provided by press release, were too limited to draw conclusions, though they hoped that colchicine, a generic medicine with manageable side effects, would prove to be beneficial for Covid-19.

The 10 Biden officials to watch on the Covid-19 response

Biden has tasked dozens of scientists, administrators, and policymakers with helping rein in the raging pandemic. Here are 10 to watch.

Are more people surviving Covid-19 because doctors are doing less?

Covid-19 has been a grim lesson in humility. We still have almost no ability to change the fate of patients with severe Covid-19 which, like many other viral infections, has turned into a graveyard for therapeutic interventions.

Pharmalittle: Pfizer to boost Covid-19 vaccine production; HHS overrules FDA on its top lawyer pick

HHS Secretary Alex Azar appointed a new top lawyer at the FDA yesterday, just hours after the agency had announced its own pick for the post.

Gilead’s remdesivir sales are surging, but investors aren’t impressed

A lot more Covid-19 patients in the U.S. are being treated with Gilead's remdesivir because of the accelerating case counts. But even with sales of the medicine surging, investors are not impressed.

Commerce Department agency proposes eliminating ‘march-in rights’ as a tool to lower drug prices

A new proposal from the National Institute of Standards and Technology would restrict the use of "march-in rights" to address prescription drug costs.

Pharmalittle: U.S. considers giving half-doses of Moderna vaccine; Americans may not get AstraZeneca shot until April

The U.S. government is considering giving some people half the dose of the Moderna Covid-19 vaccine in order to speed vaccinations.

Five key milestones in the Covid-19 pandemic that we’re anticipating in 2021

By late January, 400,000 Americans will have died of Covid-19. Can the new president and vaccines appreciably change the situation in time for the Olympics and the holidays in 2021?

As a nurse, she knew the daily traumas of Covid-19. Then her father landed in her ICU

When her father was admitted to her ICU with Covid-19, a nurse bore the weight of knowing what could come next.

Here are the nominees for best biopharma CEO of 2020

Here are the nominees for best biopharma CEO of 2020, in two separate categories.

‘I haven’t even told my wife’: Inside the frantic and secretive sprint to name the Covid-19 vaccines

‘I haven’t even told my wife’: Inside the frantic and secretive sprint to name the Covid-19 vaccines.

State attorneys general urge HHS to penalize drug makers for cutting discounts to hospitals

“Drug manufacturers are, without justification, flouting discounted pricing requirements for low-income patients," state attorneys general argue.

India’s drug regulator has failed the pandemic stress test. The U.S. should take notice

Changing drug regulation laws in India will have no effect until the people who are meant to police it have the necessary training and political will to enforce them.

Families tell U.N. Vertex is violating human rights with cystic fibrosis drug pricing

A coalition of cystic fibrosis patients and their families have filed a complaint with the United Nations, arguing that Vertex is violating human rights with its drug pricing policies.

3 reasons the drug industry should be worried about Biden’s HHS pick, Xavier Becerra

One of Xavier Becerra’s earliest policy decisions might inflict more pain on the drug industry than anything Trump’s health secretary, Alex Azar, ever threatened.

Biden’s health picks signal a bottom-up approach to the Covid-19 pandemic

Trump favored a top-down approach to responding to the coronavirus pandemic, but Biden’s surprising health official picks signal that he’ll rely far more on lower-level scientists and deputies.

Pharmalittle: Biden taps HHS and CDC heads; U.S. taxpayers may get a payback on Gilead’s remdesivir

President-elect Joe Biden picked California Attorney General Xavier Becerra to be his health secretary, putting a defender of the Affordable Care Act in a leading role to oversee the coronavirus response.

Sanguine ASH data, a remdesivir tax payout, & the reality of 20 million

Welcome to The Readout, your guide to what's new in biotech.

A payoff for U.S. taxpayers? CDC may have claims on remdesivir patents held by Gilead

If the CDC were to assert any patent rights, the agency could pursue royalties from sales of remdesivir.

Pharmalittle: FDA’s Hahn defends Covid-19 vaccine vetting; U.K. denies cutting corners to approve Pfizer shot

FDA Commissioner Stephen Hahn defended his agency’s vetting process for the Pfizer Covid-19 vaccine, saying a thorough and meticulous review is needed to assure a skeptical public.

Pharmalittle: Moderna seeking regulatory clearance for Covid-19 vaccine; charter flights begin for Pfizer vaccine

Moderna reported that its Covid-19 vaccine continued to deliver strong results, and the company will immediately seek regulatory clearances in the U.S. and Europe.

A ‘bad case of déjà vu’: New Jersey hospitals brace for Covid-19 surge, but hope this time will be different

"Now we have a little bit more knowledge, and the hope of a future vaccine," said an emergency medicine doctor. "But for patients who are sick right now, that's too late.”

Essential workers high on Covid-19 vaccine priority lists & remdesivir still backed by some doctors

The STAT Morning Rounds newsletter keeps you ahead of the day's health and science news.

Data show hospitalized Covid-19 patients are surviving at higher rates, but surge in cases could roll back gains

Patients hospitalized with Covid-19 are surviving at higher rates than in the early days of the pandemic, gains that are driven by a more refined understanding of the disease and how to treat it — and less strain on hospitals.

Pharmalittle: Pfizer asking today for emergency-use status for Covid-19 vaccine; Trump to release drug-pricing rules

Pfizer and BioNTech plan to apply Friday to the FDA for an emergency use authorization for their Covid-19 vaccine, a watershed moment in the effort to curb the global pandemic.

WHO rejects remdesivir & Eli Lilly’s antibody treatment gets complicated welcome

Welcome to The Readout, your guide to what's new in biotech.

WHO panel recommends against remdesivir use & U.S. HIV deaths nearly halved

The STAT Morning Rounds newsletter keeps you ahead of the day's health and science news.

WHO group recommends against using remdesivir to treat hospitalized Covid-19 patients

The World Health Organization says there is no evidence that the drug remdesivir improves mortality for hospitalized Covid-19 patients.